insights_auto
Why is SDGR down 2.99%?
Dive Deeperchevron_right
SDGR:NASDAQ
Schrodinger Inc
$32.39
arrow_downward
-2.99%(-1.00) 1D
Nov 10, 1:59:18 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDGR...
Open
$33.20
High
$33.78
Low
$31.61
Mkt. cap
2.43B
Avg. vol.
2.34M
Volume
984.72K
52-wk high
$33.78
52-wk low
$10.94
EPS
-$0.79
Beta
1.69
Shares outstanding
65.91M
No. of employees
850
Open
$33.20
High
$33.78
Low
$31.61
Mkt. cap
2.43B
Avg. vol.
2.34M
Volume
984.72K
52-wk high
$33.78
52-wk low
$10.94
EPS
-$0.79
Beta
1.69
Shares outstanding
65.91M
No. of employees
850
News stories
From web sources and news partners
Investing.com
·
3 hours ago
Schrödinger at UBS Global Healthcare Conference: ai push gains traction
TradingView
·
8 hours ago
Schrodinger, Inc. Stock 12‑Month Price Target Raised to $33.57, Implies 1% Upside
Investing.com Canada
·
13 hours ago
Form 144 SCHRODINGER INC For: 10 November By Investing.com
Yahoo Finance
·
2 days ago
Raised Guidance Could Change The Case For Schrödinger Stock (SDGR)
Profile
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
About Schrodinger Inc